Close

☰

News

28th January 2019

Gamidor launches new website

We are really excited to launch our new look website. The new simplified structure will allow users to quickly find the information they need and to easily contact us. If you are looking for support for your medical device, please get in touch service@gamidor.co.uk

25th January 2019

Omniguide

We are delighted to announce that Gamidor is working together with OmniGuide to deliver high quality field service for their advanced surgical systems. Together with our partners from www.timant.co.uk we will be help to support OmniGuide with their CO2 lasers and FMX Ferromagnetic range.

24th January 2019

Gamidor received certification for ISO 9001:2015

We are thrilled to be re-certified to the latest 2015 standard. We live and breathe our quality management system, using it to drive continuous improvement, so we can deliver the best possible experience to our customers.

Archives

  • ALPHASTROKE, A Better Way to Diagnose Strokes: Interview with CEO Matt Kesinger
    Posted on Tuesday February 25, 2020

    Strokes affect nearly 800,000 Americans per year. One of the most important prognostic factors is the time from symptom onset to treatment. Currently, strokes are usually diagnosed by first-responders using a quick physical exam — a subjective method that can result in incorrect diagnoses, delayed treatment, and poor outcomes. Forest Devices hopes to change that. […]

  • Wearable Magnetic Stimulator for Stroke Recovery
    Posted on Tuesday February 25, 2020

    Stroke can result in a variety of debilitating conditions caused by damaged neural connections within the brain. Researchers at the Eddy Scurlock Stroke Center at Houston Methodist Hospital in Texas have now successfully tested a wearable, multifocal, transcranial, rotating, permanent magnet stimulator (TRPMS) to boost neural activity near injured brain areas in patients recovering from […]

  • Abbott’s Gallant Cardiac Implants Cleared in Europe
    Posted on Tuesday February 25, 2020

    Abbott won clearance in the European Union for its new Gallant implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) implants. The MRI compatible devices, which Abbott claims have an extended battery lifetime, can securely communicate with patients and physicians via Abbott’s myMerlinPulse smartphone app. Physicians can monitor their patients, including being able to […]

  • Tactile Enhancement to Compensate for Loss of Sensation
    Posted on Monday February 24, 2020

    A variety of medical conditions, including diabetic neuropathy, infections, and injuries, can lead to a reduced ability to feel touch with one’s skin. This can be frustrating and uncomfortable, but it can also result in an inability to walk in comfort, notice wounds and injuries, and deal with everyday tasks. Now researchers in China are […]

  • Novalung FDA Cleared to Provide Long-Term Lung Failure Treatment
    Posted on Monday February 24, 2020

    Critically ill patients with acute respiratory or cardiopulmonary failure who are on long-term mechanical ventilation too often suffer a variety of side effects. These can include ventilator associated lung injury, pneumonia, and diaphragm dysfunction. Moreover, related sedation and lack of movement can aggravate an already difficult situation. To help address some of the challenges of […]